+ Filter
Loading...
Custom Services order now ship next day

Durvalumab

Loading...

Anti-Durvalumab Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Background

Durvalumab is a human IgG1 kappa monoclonal antibody and immune-checkpoint inhibitor approved for use with etoposide and either carboplatin or cisplatin as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC).
Go to compare

Go to compare